ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 6 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnoea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries.
How a San Diego-based S&P 500 company and global leader in remote monitoring software began halfway around the world with one inventor and one investor.
Our mission is to change 20 million lives by 2020. We're proud to make equipment and connected health solutions that give those with sleep apnoea, COPD and other respiratory diseases the gift of breath.
ResMed’s executive team is committed to the highest standards of ethics and professional integrity that translate into great partnerships with our customers, suppliers and the global ResMed team.
ResMed changes lives by developing, manufacturing and distributing innovative medical devices and cloud-based software solutions to better diagnose, treat, and manage sleep-disordered breathing, COPD, and other key chronic diseases.
Read about some recent research in the industry.